So the question is not really whether alcohol kills your gains in one night
Its an important message, Scott Isaacs, MD, president of the American Association of Clinical Endocrinology, told Healthline
doi:10.1056/NEJMoa2301972
The ongoing dedicated ophthalmic trial named as FOCUS study, which aims to evaluate semaglutides long-term effects on diabetic retinopathy, is now ongoing and could contribute to a comprehensive understanding of the true risk-benefit profile of these agents in patients with or at risk for diabetic retinopathy (NCT03811561) [104]
Two small randomized controlled trials in people with prediabetes found that taking 200 mg of Eriomin daily was linked to a modest bump in GLP-1 blood levels17% in one study, 22% in the other
When activated with GLP-1r, GIP seems to potentiate not only the weight loss mechanism of the incretin but also the glucose lowering effects [13]